What's breaking now, across thousands of outlets.
Migraine prevention drugs are more targeted than ever before, and new guidelines may help doctors predict which will work for each patient.
We haven't written up this one. Science News has the full story — the link below goes straight to it.
Some four months after the White House inked the last of its expected drug pricing deals with 17 of the industry’s top players, the U.S.
Nine new companies have announced voluntary drug pricing deals with the White House, looking to avoid industry tariffs and inclusion in two CMS pilot programs under review that are thought to be…
President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making such agreements.
To help clinicians determine which medications may be most effective at preventing migraine in adults, the American Academy of Neurology (AAN) and American Headache Society (AHS) have issued a joint…
New research reveals that living in a democracy is linked to better mental health, primarily because it fulfills a basic psychological need for autonomy.
The Trump administration on Monday announced new Medicaid drug pricing agreements with nine midsize biotechnology and pharmaceutical companies.
